{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:34:07Z","timestamp":1772253247710,"version":"3.50.1"},"reference-count":109,"publisher":"Baishideng Publishing Group Inc.","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i43.15965","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T06:17:23Z","timestamp":1457763443000},"page":"15965","source":"Crossref","is-referenced-by-count":11,"title":["New treatments for chronic hepatitis C: An overview for paediatricians"],"prefix":"10.3748","volume":"20","author":[{"given":"Daniele","family":"Serranti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Resti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0928"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01934.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21437"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10405"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318258328d"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.139410"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i4.419"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S36247"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-7347.2011.11.001"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/704912"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.028"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.016"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.047"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i2.99"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1031"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nature08309"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.056"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.447"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ng.449"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1799-z"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31828febf0"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-010-0078-7"},{"key":"ref24","unstructured":"Serranti D, Buonsenso D, Ceccarelli M, Gargiullo L, Ranno O, Valentini P. Pediatric hepatitis C infection: to treat or not to treat...what’s the best for the child? Eur Rev Med Pharmacol Sci 2011;15:1057-1067."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0897190010367737"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-125906"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2012.03603.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5789"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.27847"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.11.008"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01089.x"},{"key":"ref32","unstructured":"Nadeem A, Aslam M, Khan DA, Hussain T, Khan SA. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C. J Coll Physicians Surg Pak 2009;19:86-89."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181b99cf0"},{"key":"ref34","unstructured":"Veluru C, Atluri D, Chadalavada R, Burns E, Mullen KD. Skin rash during chronic hepatitis C therapy. Gastroenterol Hepatol (N Y) 2010;6:323-325."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mistry N, Shapero J, Crawford RI. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol 2009;23:677-683.","DOI":"10.1155\/2009\/651952"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01496-06"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.31"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27340-7_5"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27340-7_7"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01451.x"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i43.6183"},{"key":"ref42","unstructured":"Tran TT. A review of standard and newer treatment strategies in hepatitis C. Am J Manag Care 2012;18:S340-S349."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.037"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.08.009"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"ref47","unstructured":"Wyles DL. Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection. Top Antivir Med 2012;20:139-145."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2012.09.011"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.011"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.055"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002832"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041191"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039652"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.013"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2012.10.010"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P744"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25653"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Wilby KJ, Greanya ED, Ford JA, Yoshida EM, Partovi N. A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients. Ann Hepatol 2012;11:179-185.","DOI":"10.1016\/S1665-2681(19)31022-1"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.01.042"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00253-11"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1021\/jm401836p"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666131228222215"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.030"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24609"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i11.2902"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.06.014"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24594"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-355"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S40310"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.795543"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990178"},{"key":"ref72","unstructured":"Varshney J, Sharma PK, Sharma A. A review on an update of NS5B polymerase hepatitis C virus inhibitors. Eur Rev Med Pharmacol Sci 2012;16:667-671."},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.09.007"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.2174\/187152606776056724"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.775246"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"ref77","unstructured":"A special meeting review edition: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2013: The 48th Annual Meeting of the European Association for the Study of the LiverApril 24-28, 2013 • Amsterdam, The NetherlandsSpecial Reporting on: • Simeprevir Plus Peginterferon\/Ribavirin Is Associated with a High SVR12 Rate in Treatment-Naive Patients with Genotype 1 Hepatitis C Virus Infection• Addition of Simeprevir to Peginterferon\/Ribavirin Is Associated with Faster Resolution of Fatigue in Treatment-Naive Patients• Sofosbuvir Plus Ribavirin Demonstrates Significant Efficacy in Multiple HCV Genotype 2\/3 Populations• Daclatasvir Plus Sofosbuvir with or without Ribavirin Yields 100% SVR24 Rate in Genotype 1 Patients Who Fail Telaprevir or Boceprevir• Addition of TG4040 Vaccine to Peginterferon\/Ribavirin Increases Sustained Virologic Response Rate at 24 Weeks in Genotype 1 Hepatitis C InfectionPLUS Meeting Abstract Summaries With Expert Commentary by: Ira M. Jacobson, MDJoan Sanford I. Weill Medical College at Cornell UniversityNew York, New York. Gastroenterol Hepatol (N Y) 2013;9:1-18."},{"key":"ref78","unstructured":"Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia ES, Brainard DM, Symonds WT. Sofosbuvir Ribavirin for 12 or 24 Weeks for Patients With HCV Genotype 2 or 3: the VALENCE Trial. Proceedings of the 64th Annual Meeting of the American Association for the Study of Liver Diseases USA: Washington, DC; 2013;1-5."},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12028"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1021\/jm201384j"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/13305"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24342"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.015"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.627851"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S30946"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Frausto SD, Lee E, Tang H. Cyclophilins as modulators of viral replication. Viruses 2013;5:1684-1701.","DOI":"10.3390\/v5071684"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000546"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2013.17.5.375"},{"key":"ref89","unstructured":"Watashi K. Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection. Curr Opin Investig Drugs 2010;11:213-224."},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22835"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.015"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22131"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178178"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2766"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0318-9"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-012-2036-3"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt852"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209026"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2009.10.012"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1038\/ni875"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003;4:63-68.","DOI":"10.1038\/ni873"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0078"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.23820"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21312"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02239-12"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70138-X"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104430"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/825375"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i43\/15965.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T09:46:37Z","timestamp":1567676797000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i43\/15965.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":109,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i43.15965","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725263666.793502184","asserted-by":"object"}]},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}